US Reciprocal Tariffs: Seven Trade Barrier Issues Indonesia Must Address
Jakarta, CNBC Indonesia — United States President Donald Trump has officially imposed reciprocal tariffs on 86 countries, including Indonesia at a rate of 32%. The tariffs take into account a number of trade barriers.
Through its Department of Commerce, the US has raised several objections to Indonesia's trade practices. These objections were conveyed in the 2025 National Trade Estimate Report on Foreign Trade Barriers of the President of the United States on the Trade Agreements Program.
In the report, the US raised a number of concerns regarding cumbersome and multi-layered import licensing requirements as well as halal certification.
In response to this situation, on 7 April 2025, Indonesia's Coordinating Ministry for Economic Affairs announced the Progress of Cross-Ministry/Agency Coordination on Foreign Trade Barrier Issues raised by the USTR — an initial step to detail Indonesia's position and response. The following are the seven issues in full:
Table 1: Import Licensing Issues
Table 2: Customs Barriers and Trade Facilitation Issues
Table 3: Pharmaceutical Market Access Issues
Table 4: Local Content/TKDN Issues
Table 5: Agricultural Products Issues
Table 6: Quantitative Restriction Issues
Table 7: State Trading Issues
Through its Department of Commerce, the US has raised several objections to Indonesia's trade practices. These objections were conveyed in the 2025 National Trade Estimate Report on Foreign Trade Barriers of the President of the United States on the Trade Agreements Program.
In the report, the US raised a number of concerns regarding cumbersome and multi-layered import licensing requirements as well as halal certification.
In response to this situation, on 7 April 2025, Indonesia's Coordinating Ministry for Economic Affairs announced the Progress of Cross-Ministry/Agency Coordination on Foreign Trade Barrier Issues raised by the USTR — an initial step to detail Indonesia's position and response. The following are the seven issues in full:
Table 1: Import Licensing Issues
Table 2: Customs Barriers and Trade Facilitation Issues
Table 3: Pharmaceutical Market Access Issues
Table 4: Local Content/TKDN Issues
Table 5: Agricultural Products Issues
Table 6: Quantitative Restriction Issues
Table 7: State Trading Issues